GSTM1 and chronic kidney disease: In patients with non-dialysis-dependent (ND)-CKD, several clinical studies and a meta-analysis have shown improvements in hemoglobin (Hb) and/or iron status in response to i.v. iron [18–25] and suggest that i.v. iron treatment may prevent or delay the need for ESA initiation [21–23,26].